At QurAlis, we are neuro pioneers on a quest to cure, boldly seeking to translate scientific breakthroughs into powerful precision medicines. We work collaboratively with a relentless pursuit of knowledge, precise attention to craft, and compassion to discover and develop medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases. QurAlis is the leader in development of precision therapies for amyotrophic lateral sclerosis (ALS). In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases defined by genetics and clinical biomarkers.
| Website | https://quralis.com/ |
| Revenue | $30.4 million |
| Employees | 77 (56 on RocketReach) |
| Founded | 2016 |
| Address | 35 Cambridgepark Dr 300, Cambridge, Massachusetts 02140, US |
| Phone | +1 781-816-7031 |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering, Health Care, Therapeutics |
| Keywords | Neurology, Precision Medicine, Biotechnology, Drug Development, Neuroscience Research, Neurological Disorders, Pharmaceutical, Central Nervous System, Drug Discovery, Innovative Medicines, Therapeutics, Biopharma, Biotechnology Research, Pharmaceutical Research, Clinical Trials, Research And Development, Clinical Development, Life Sciences, Healthcare, Medicine |
| Competitors | Novartis, Pfizer, AstraZeneca, Catalent Pharma Solutions, Moderna Therapeutics, Arcturus Therapeutics, CureVac, Zymeworks Inc., Ribometrix Inc. +37 more (view full list) |
Looking for a particular QurAlis employee's phone or email?
The QurAlis annual revenue was $30.4 million in 2026.
Jason Brown is the CFO and COO of QurAlis.
56 people are employed at QurAlis.
QurAlis is based in Cambridge, Massachusetts.